Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-16-142026

Director sold 7,500 shares at $19.13 ($143,475)

  • Director acquired 15,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

KUEBLER CHRISTOPHER A · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2016-09-15 Exercise or conversion : show line 1 in the form +15,000 35,000 D
2016-09-16 Sale : show line 2 in the form −7,500 $19.13 $143,475 27,500 D
Open-market sales · 7,500 sh · avg $19.13 · $143,475

Table II: Derivative

1 line
Date Transaction Shares Underlying Owned after D/I
2016-09-15 Exercise or conversion : show line 3 in the form Restricted Stock Unit −15,000 15,000 0 D
Loading xslF345X03/doc4.xml…